Skip Nav Destination
Issue Highlights
- Using HSC-targeted nanoparticles to create a mouse model of α-thalassemia and gene therapy treatment
- NGS-based stratification improves risk assessment in T-ALL
- Preclinical insights into checkpoint inhibitor–induced AIHA
- Optimizing drug combinations for T-PLL
- Molecular taxonomy of myelodysplastic syndromes
- Review: the intestinal microbiota and its influence on cellular therapy
Latest in Blood
Xiaosu Zhou; Xue Chen; Jiaqi Chen; Lijun Wen; Zhanglin Zhang; Ya-Zhen Qin; Panxiang Cao; Haizhou Xing; Yingchang Mi; Wei Wang; Guangsen Zhang; Ji Li; Huanling Wu; Zhifen Zhang; Jian Zhang; Zhan Su; Fang Wang; Yang Zhang; Xiaoli Ma; Jiancheng Fang; Ping Wu; Tong Wang; Gaowei Fan; Yang Zhao; David Jin; Xian Zhang; Xiujuan Ma; Qisheng Wu; Zhihua Zhang; Linya Wang; Futian Ma; Xia Xiao; Chengye Wu; Kai Sun; Ruijie Tang; Yun Zhang; Sanyun Wu; Ran Gao; Leping Zhang; Huyong Zheng; Yanli Zhao; Hong-Hu Zhu; Daopei Lu; Peihua Lu; Suning Chen; Hongxing Liu
Mathieu Simonin; Loïc Vasseur; Etienne Lengliné; Ludovic Lhermitte; Aurélie Cabannes-Hamy; Marie Balsat; Aline Schmidt; Marie-Emilie Dourthe; Aurore Touzart; Carlos Graux; Nathalie Grardel; Jean-Michel Cayuela; Isabelle Arnoux; Virginie Gandemer; Françoise Huguet; Stéphane Ducassou; Véronique Lhéritier; Yves Chalandon; Norbert Ifrah; Hervé Dombret; Elizabeth Macintyre; Arnaud Petit; Philippe Rousselot; Jérôme Lambert; André Baruchel; Nicolas Boissel; Vahid Asnafi
Advertisement intended for health care professionals